Disclosures for "Lessons Learned from a Decade of Parallel Sequencing in Neuromuscular Disorders: RNA splicing variant detection boosts diagnostic rate from 40% to 62%.")
-
Prof. Cooper has stock in Frontier Genomics Pty Ltd. An immediate family member of Prof. Cooper has stock in Frontier Genomics Pty Ltd. The institution of Prof. Cooper has received research support from The National Health and Medical Research Council of Australia. The institution of Prof. Cooper has received research support from The NHMRC Medical Research Futures Fund. The institution of Prof. Cooper has received research support from The Luminesce Alliance for Child Health. The institution of Prof. Cooper has received research support from The Lenity Foundation. Prof. Cooper has received intellectual property interests from a discovery or technology relating to health care. Prof. Cooper has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Prof. Cooper has received intellectual property interests from a discovery or technology relating to health care.